LongeVC targets $250m for Fund II, bets on opportunities in Asia's longevity tech growth

LongeVC targets $250m for Fund II, bets on opportunities in Asia's longevity tech growth

Garri Zmudze, managing partner and co-founder of LongeVC. Photo from LongeVC

07 May, 2024

Edited by: Padma Priya

AI biotech Garri Zmudze Insilico Medicine LongeVC longevity pet health

Printed by Unregistered user on Tue, 15 Jul 2025 22:18:15 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Policy & Regulations

US lawmakers call for sanctions on China's WuXi AppTec biotech firm

SE Asian biotech startups get a shot in the arm post-pandemic, but road ahead ain't easy

Read more from Greater China

Uber, Baidu team up to launch self-driving taxis in global markets

Policy & Regulations

HK lays out proposals to regulate ride-hailing players like Uber